Concepedia

Haris Ali

HA

50

Publications

2K

Citations

22

H-Index

2016

Active since

Affiliations

City of Hope(Current)

City Of Hope National Medical Center

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Haris Ali is an author at City of Hope specializing in medicine, hematology, and transplantation.

ORCID

Top concepts

Publications per year

2016–2024

50

Publications

50

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

Madan Jagasia, Miguel‐Angel Perales, Mark A. Schroeder et al. · Blood · 2020 · 289 citations · Full text

Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia

Bin Zhang, Le Xuan Truong Nguyen, Ling Li et al. · Nature Medicine · 2018 · 153 citations · Full text

, , +11

Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

Aaron T. Gerds, Jason Gotlib, Haris Ali et al. · Journal of the National Comprehensive Cancer Network · 2022 · 119 citations · Full text

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia

Anthony S. Stein, Joycelynne Palmer, Ni‐Chun Tsai et al. · Biology of Blood and Marrow Transplantation · 2017 · 95 citations · Full text

, , +14

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Mark A. Schroeder, H. Jean Khoury, Madan Jagasia et al. · Blood Advances · 2020 · 94 citations · Full text

Rows per page

1–5 of 50